Maine · 86664

Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in Maine

Maine Medicare Avg
$14.14
5% below national avg
National Medicare Avg
$14.94
All states combined
Billed Charge (ME)
$66.45
What providers submit
Est. Commercial (ME)
$31.10
National avg: $33.46
Est. Cash / Self-Pay (ME)
$28.88
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

29
Services in ME
4
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Maine

Provider Medicare Services
Nordx $14.04 26

Maine Pricing in Context

In Maine, CPT code 86664 (Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen) carries an average Medicare payment of $14.14 — 5% below the national benchmark of $14.94. 4 providers across the state submitted claims for this procedure in 2023, performing 29 total services. Individual payments in ME ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Maine is $66.45, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Maine sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Maine lands near $31.10, with self-pay cash prices typically around $28.88. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cost in Maine?

The average Medicare payment for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in Maine is $14.14, which is 5% below the national average of $14.94. Providers in ME typically bill $66.45 for this procedure.

What does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cost with insurance in Maine?

With commercial insurance in Maine, Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen costs an estimated $31.10. Without insurance, the estimated cash price is $28.88. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in Maine?

4 providers in Maine billed Medicare for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in 2023, performing 29 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cheaper in Maine than the national average?

Yes — Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen costs 5% below the national average in Maine. The state average Medicare payment is $14.14 compared to $14.94 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial